A Range of Research-Based Pharmacotherapies for Addiction-Reference-Cited by-同舟云学术

A Range of Research-Based Pharmacotherapies for Addiction

Published:1997-10-03 Issue:5335 Volume:278 Page:66-70
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

O'Brien Charles P.¹

Affiliation:

1. The author is at the University of Pennsylvania VA Medical Center, 3900 Chestnut Street, Philadelphia, PA 19104–6178, USA.

Abstract

Modern approaches to the treatment of addiction have been influenced by several important factors. These include advances in our understanding of the nature of addiction based on longitudinal studies, and progress in elucidating the biological underpinnings of addictive behavior. In addition, changes in the system for delivery of services have begun to shape the way that addiction is treated.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference62 articles.

1. M. B. First Ed. Diagnostic and Statistical Manual of Mental Disorders DSM-IV (American Psychiatric Association Washington DC ed. 4 1994).

2. C. P. O'Brien in The Pharmacological Basis of Therapeutics J. G. Hardman and L. E. Limbird Eds. (McGraw-Hill New York ed. 9 1995) pp. 557–577.

3. LeBlanc A. E., Kalant H., Gibbins R. J., Berman N. D., J. Pharmacol. Exp. Ther. 168, 244 (1969).

4. Cleeland C. S., et al., N. Engl. J. Med. 330, 592 (1994).

5. Foley K., ibid. 336, 54 (1997).

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conflicting theories on addiction aetiology and the strengths and limitations of substance use disorder disease modelling;Frontiers in Molecular Neuroscience;2023-09-06

2. Drug Addiction and Incarceration: A Call for Research and Transparency Among Prison-Based Substance Abuse Treatment Programs;International Journal of Offender Therapy and Comparative Criminology;2023-06-05

3. Cannabidiol decreases motivation for cocaine in a behavioral economics paradigm but does not prevent incubation of craving in mice;Biomedicine & Pharmacotherapy;2022-04

4. Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder;Frontiers in Pharmacology;2022-03-01

5. Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Reinstatement of Cocaine-Mediated Conditioned Place Preference in Mice;Frontiers in Behavioral Neuroscience;2022-01-05